| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 01/09/2003 | WO2002072536A8 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 01/09/2003 | US20030009036 To produce polymers; cancer therapy |
| 01/08/2003 | EP1272465A2 Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality |
| 01/08/2003 | EP1272464A1 Gold nanoparticles |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1025080B1 Process for the recycle of a waste product of diltiazem synthesis |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1098252C Process for the preparation of 2-hydroxy-4-(methylthio) butanoic acid or methionine by mercaptan addition |
| 01/07/2003 | US6504049 Process for synthesizing pharmaceutically active disulfide salts |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | CA2124784C Pentanoic acid derivatives |
| 01/03/2003 | WO2002038850A3 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004072 Contains photo-labile unit which upon exposure to electromagnetic radiation is capable of releasing a pro-accord unit such as an aldehyde or ketone |
| 01/02/2003 | EP1270584A1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1270535A2 Method to synthesise substituted aromatic compounds |
| 01/02/2003 | EP1268653A2 Carbon black coupler |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1268396A1 Diphenyl ether compounds useful in therapy |
| 01/02/2003 | EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 01/01/2003 | CN1388117A Process for prodcing 3-aryl sulfate iso-hydroximic acid |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500985 Process for producing alpha-aminoketones |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500213 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 12/27/2002 | WO2002103340A2 Method and device for the detection of trace amounts of a substance,using a piezoelectric crystal element |
| 12/27/2002 | WO2002102389A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 12/27/2002 | WO2002082185B1 Perfluoroalkylsulfonic acid compounds for photoresists |
| 12/27/2002 | WO2002072540A3 Improved methods of ortho alkylation |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/26/2002 | US20020198410 Process for the preparation of diorganotrisulfide |
| 12/26/2002 | US20020198399 Useful as intermediates or raw materials for the synthesis of agricultural chemicals, pharmaceuticals |
| 12/26/2002 | US20020198376 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis |
| 12/26/2002 | US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020198107 Delivery systems for cyclopropenes |
| 12/26/2002 | US20020197558 Photoacid generators for use in photoresist compositions |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/25/2002 | CN1387507A Diaryl-enynes |
| 12/25/2002 | CN1387506A Prodction of aryl carboxylate esters |
| 12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498265 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
| 12/24/2002 | US6498196 Thio-aminotetralins; analgesics; opioid receptor affinity; side effect reduction |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498180 Such as 2-(3'-hydroxymethyl-2'-carboxycyclopropyl)glycine; modulating metabotropic glutamate receptor; treating disorders of central nervous |
| 12/24/2002 | US6498150 Low molecular weight cell, bone marrow and immune stimulants |
| 12/24/2002 | US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002100903A1 Oxime ester photoinitiators having a combined structure |
| 12/19/2002 | WO2002100850A1 Processes for preparation of heterocyclic compounds |
| 12/19/2002 | WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 12/19/2002 | WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002100341A2 Compounds for the treatment of metabolic disorders |
| 12/19/2002 | WO2002100339A2 Novel process for preparing rac-bicalutamide and its intermediates |
| 12/19/2002 | WO2002100295A2 Facially amphiphilic polymers as anti-infective agents |
| 12/19/2002 | WO2002100172A1 Administration of agents via the pept-2 transporter |
| 12/19/2002 | WO2002057222A3 Thiol-based naaladase inhibitors |
| 12/19/2002 | WO2002042248A3 Naphthalene derivatives |
| 12/19/2002 | US20020193634 Disulfide derivatives useful for treating allergic diseases |
| 12/19/2002 | US20020193633 Mast cell stabilizers |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193446 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 12/19/2002 | US20020193414 Adamantane derivatives |
| 12/19/2002 | US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 12/19/2002 | CA2451117A1 Facially amphiphilic polymers as anti-infective agents |
| 12/19/2002 | CA2450205A1 Aminediols for the treatment of alzheimer's disease |
| 12/19/2002 | CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | CA2448571A1 Novel process for preparing rac-bicalutamide and its intermediates |
| 12/19/2002 | CA2446722A1 Oxime ester photoinitiators having a combined structure |
| 12/18/2002 | EP1266886A1 Process for producing 4-bromothioanisole |
| 12/18/2002 | EP1266885A1 Process for preparing 2-hydroxy-4-methylthiobutanoic acid |
| 12/18/2002 | EP1266884A1 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same |
| 12/18/2002 | EP1265940A2 Aromatic amine curatives and their use |
| 12/18/2002 | EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 12/18/2002 | EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/18/2002 | EP1265852A1 Substituted imide derivatives |
| 12/18/2002 | EP1265850A2 Insecticidal anthranilamides |
| 12/18/2002 | EP1265839A1 Compounds active at the glucocorticoid receptor |
| 12/18/2002 | EP1265838A1 Novel fatty acid analogous |
| 12/17/2002 | US6495713 Reacting pivaloyl chloride with hydroxyketosulfide compound and trialkylamine in the presence of a catalyst in a substantially non-reactive solvent to form ketoester sulfide compound; oxidizing to form ketoester sulfone compound |
| 12/17/2002 | US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 12/17/2002 | US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine |
| 12/17/2002 | US6495546 Propanolamine derivatives |
| 12/12/2002 | WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
| 12/12/2002 | WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 12/12/2002 | WO2002098846A1 Sulfonamide derivatives |
| 12/12/2002 | WO2002098559A2 Organoaluminum catalyst, its preparation and its use in a process for the polymerization of alkylene oxides |